Momenta Pharmaceuticals, Inc. (MNTA) Is At $20.20 Formed Wedge; Pro Dex (PDEX) Sentiment Is 1.5

April 18, 2018 - By Adrian Erickson

Pro-Dex, Inc. (NASDAQ:PDEX) Logo

Momenta Pharmaceuticals, Inc. (MNTA) formed wedge up with $21.61 target or 7.00% above today’s $20.20 share price. Momenta Pharmaceuticals, Inc. (MNTA) has $1.55B valuation. The stock increased 3.32% or $0.65 during the last trading session, reaching $20.2. About 975,709 shares traded or 13.11% up from the average. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) has risen 23.66% since April 18, 2017 and is uptrending. It has outperformed by 12.11% the S&P500.

Pro Dex Inc (PDEX) investors sentiment decreased to 1.5 in Q4 2017. It’s down -5.50, from 7 in 2017Q3. The ratio has worsened, as 6 hedge funds increased or opened new holdings, while 4 cut down and sold equity positions in Pro Dex Inc. The hedge funds in our database now have: 256,735 shares, down from 312,758 shares in 2017Q3. Also, the number of hedge funds holding Pro Dex Inc in top ten holdings was flat from 0 to 0 for the same number . Sold All: 1 Reduced: 3 Increased: 4 New Position: 2.

Investors sentiment decreased to 1.45 in 2017 Q4. Its down 0.28, from 1.73 in 2017Q3. It dropped, as 19 investors sold Momenta Pharmaceuticals, Inc. shares while 36 reduced holdings. 23 funds opened positions while 57 raised stakes. 71.96 million shares or 2.47% more from 70.23 million shares in 2017Q3 were reported. Envestnet Asset Mngmt invested 0% in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). Bankshares Of Ny Mellon stated it has 0% in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). Piedmont Investment Advisors Limited Liability holds 0% in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) or 15,701 shares. State Board Of Administration Of Florida Retirement System holds 53,502 shares. Gsa Ptnrs Limited Liability Partnership reported 113,294 shares or 0.1% of all its holdings. 37 were reported by Parkside Financial Bank. Metropolitan Life Ins Communication New York invested 0% of its portfolio in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). 231,862 were reported by Jacobs Levy Equity Mngmt. Axa has invested 0% in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). Ameritas Prtn stated it has 6,446 shares. Amica Retiree Med Trust has 11,264 shares. Profund Advsr Limited owns 11,630 shares. Principal holds 617,690 shares or 0.01% of its portfolio. Ny State Teachers Retirement System reported 110,316 shares. 66,687 were accumulated by Citigroup.

Among 12 analysts covering Momenta Pharmaceuticals (NASDAQ:MNTA), 5 have Buy rating, 2 Sell and 5 Hold. Therefore 42% are positive. Momenta Pharmaceuticals had 29 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Hold” rating by Cowen & Co given on Tuesday, October 31. Barclays Capital maintained the shares of MNTA in report on Wednesday, October 4 with “Equal-Weight” rating. The stock has “Sell” rating by Maxim Group on Thursday, August 3. As per Friday, January 8, the company rating was upgraded by Maxim Group. The company was downgraded on Wednesday, February 22 by Leerink Swann. Barclays Capital downgraded the shares of MNTA in report on Monday, May 22 to “Equal-Weight” rating. The rating was initiated by Goldman Sachs on Monday, June 6 with “Neutral”. The stock of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) has “Overweight” rating given on Tuesday, October 11 by Barclays Capital. The stock of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) earned “Hold” rating by Aegis Capital on Tuesday, November 22. Leerink Swann maintained the stock with “Outperform” rating in Wednesday, May 4 report.

Since December 13, 2017, it had 0 insider buys, and 12 sales for $2.01 million activity. WHEELER CRAIG A sold 3,938 shares worth $64,800. Leicher Bruce also sold $75,333 worth of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) shares. $11,846 worth of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) was sold by Kaundinya Ganesh Venkataraman on Wednesday, February 21. On Monday, February 12 the insider Storer Scott M sold $60,216. Another trade for 16,264 shares valued at $292,752 was made by Stoner Elizabeth on Tuesday, January 30.

First Wilshire Securities Management Inc holds 0.03% of its portfolio in Pro-Dex, Inc. for 14,000 shares. Thompson Davis & Co. Inc. owns 2,000 shares or 0.03% of their US portfolio. Moreover, Bridgeway Capital Management Inc has 0.01% invested in the company for 76,600 shares. The Massachusetts-based Acadian Asset Management Llc has invested 0% in the stock. Blackrock Inc., a New York-based fund reported 655 shares.

Pro-Dex, Inc., together with its subsidiaries, designs, develops, and makes powered surgical instruments for medical device original equipment manufacturers, dental instruments, and rotary air motors worldwide. The company has market cap of $30.02 million. It also makes plastic injection molds for various industries; and machined parts. It has a 11.14 P/E ratio. Further, it provides engineering consulting and placement services, as well as quality and regulatory consulting services.

Since January 1, 0001, it had 1 buying transaction, and 0 insider sales for $14,850 activity.

Pro-Dex, Inc. (NASDAQ:PDEX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>